Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Presterl, E.
Nadrchal, R.
Winkler, S.
Makristathis, A.
Koller, W.
Rotter, M. L.
and
Hirschl, A. M.
1997.
Molecular typing ofAcinetobacter baumannii from ten different intensive care units of a university hospital.
European Journal of Clinical Microbiology & Infectious Diseases,
Vol. 16,
Issue. 10,
p.
740.
Villari, Paolo
Iacuzio, Luigi
Vozzella, Emilia Anna
and
Bosco, Umberto
1999.
Unusual genetic heterogeneity of Acinetobacter baumannii isolates in a university hospital in Italy.
American Journal of Infection Control,
Vol. 27,
Issue. 3,
p.
247.
Costa, S.F
Woodcock, J
Gill, M
Wise, R
Barone, A.A
Caiaffa, H
and
Levin, A.S.S
2000.
Outer-membrane proteins pattern and detection of β-lactamases in clinical isolates of imipenem-resistant Acinetobacter baumannii from Brazil.
International Journal of Antimicrobial Agents,
Vol. 13,
Issue. 3,
p.
175.
Tenover, Fred C.
2001.
Development and Spread of Bacterial Resistance to Antimicrobial Agents: An Overview.
Clinical Infectious Diseases,
Vol. 33,
Issue. s3,
p.
S108.
García‐Garmendia, José‐Luis
Ortiz‐Leyba, Carlos
Garnacho‐Montero, José
Jiménez‐Jiménez, Francisco‐Javier
Pérez‐Paredes, Carmen
Barrero‐Almodóvar, Ana E.
and
Gili‐Miner, Miguel
2001.
Risk Factors forAcinetobacter baumanniiNosocomial Bacteremia in Critically Ill Patients: A Cohort Study.
Clinical Infectious Diseases,
Vol. 33,
Issue. 7,
p.
939.
Costa, S.F.
Newbaer, M.
Santos, C.R.
Basso, M.
Soares, I.
and
Levin, A.S.S.
2001.
Nosocomial pneumonia: importance of recognition of aetiological agents to define an appropriate initial empirical therapy.
International Journal of Antimicrobial Agents,
Vol. 17,
Issue. 2,
p.
147.
Levin, Anna S
Levy, Carlos E
Manrique, A.Edison I
Medeiros, Eduardo A.S
and
Costa, Silvia F
2003.
Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam.
International Journal of Antimicrobial Agents,
Vol. 21,
Issue. 1,
p.
58.
Reis, Adriana O.
Luz, Deise A.M.
Tognim, Maria C.B.
Sader, Hélio S.
and
Gales, Ana C.
2003.
Polymyxin-ResistantAcinetobacterspp. Isolates: What Is Next?.
Emerging Infectious Diseases,
Vol. 9,
Issue. 8,
p.
1023.
Gales, Ana Cristina
Pfaller, Michael A.
Sader, Helio S.
Hollis, Richard J.
and
Jones, Ronald N.
2004.
Genotypic Characterization of Carbapenem-NonsusceptibleAcinetobacterspp. Isolated in Latin America.
Microbial Drug Resistance,
Vol. 10,
Issue. 4,
p.
286.
Braun, Graziela
and
Vidotto, Marilda Carlos
2004.
Evaluation of adherence, hemagglutination, and presence of genes codifying for virulence factors of Acinetobacter baumannii causing urinary tract infection.
Memórias do Instituto Oswaldo Cruz,
Vol. 99,
Issue. 8,
p.
839.
Akıncı, E.
Çolpan, A.
Bodur, H.
Balaban, N.
and
Erbay, A.
2005.
Risk factors for ICU-acquired imipenem-resistant Gram-negative bacterial infections.
Journal of Hospital Infection,
Vol. 59,
Issue. 4,
p.
317.
Falagas, M.E.
and
Kopterides, P.
2006.
Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature.
Journal of Hospital Infection,
Vol. 64,
Issue. 1,
p.
7.
Motaouakkil, Said
Charra, Boubaker
Hachimi, Abdelhamid
Nejmi, Hicham
Benslama, Abdellatif
Elmdaghri, Naima
Belabbes, Habiba
and
Benbachir, Mohamed
2006.
Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii.
Journal of Infection,
Vol. 53,
Issue. 4,
p.
274.
Katsaragakis, Stilianos
Markogiannakis, Haridimos
Toutouzas, Konstantinos G.
Drimousis, Panagiotis
Larentzakis, Andreas
Theodoraki, Eleni‐Maria
and
Theodorou, Dimitrios
2008.
Acinetobacter baumanniiInfections in a Surgical Intensive Care Unit: Predictors of Multi‐drug Resistance.
World Journal of Surgery,
Vol. 32,
Issue. 6,
p.
1194.
Yang, Ce
Zhou, Lin-Lin
Wang, Hai-Yan
Huang, Su-Na
Liu, Qing
Hu, Shi-Lin
Li, Ting-Rong
Chen, Yan-Bing
and
Jiang, Jian-Xin
2011.
The inhibitory effect of Zingiber corallinum Hance essential oil on drug-resistant bacteria and evaluation of its acute toxicity.
Medical Science Monitor,
Vol. 17,
Issue. 5,
p.
BR139.
Longjam, Langamba A
Tsering, Dechen C
and
Das, Dipmala
2023.
Molecular Characterization of Class A-ESBLs, Class B-MBLs, Class C-AmpC, and Class D-OXA Carbapenemases in MDR Acinetobacter baumannii Clinical Isolates in a Tertiary Care Hospital, West Bengal, India.
Cureus,